FAM65A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.986100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.916180E-01
Normal-vs-Stage2
6.224500E-02
Normal-vs-Stage3
1.643430E-01
Normal-vs-Stage4
4.424400E-01
Stage1-vs-Stage2
1.710410E-01
Stage1-vs-Stage3
6.532400E-01
Stage1-vs-Stage4
3.553600E-02
Stage2-vs-Stage3
4.831600E-01
Stage2-vs-Stage4
4.146400E-01
Stage3-vs-Stage4
2.506800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.260000E-02
Normal-vs-AfricanAmerican
1.102610E-01
Normal-vs-Asian
1.342020E-01
Caucasian-vs-AfricanAmerican
6.354400E-01
Caucasian-vs-Asian
7.178200E-01
AfricanAmerican-vs-Asian
8.848200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.839700E-02
Normal-vs-Female
2.442400E-02
Male-vs-Female
5.367200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.535400E-01
Normal-vs-Age(41-60Yrs)
1.117560E-01
Normal-vs-Age(61-80Yrs)
3.064100E-02
Normal-vs-Age(81-100Yrs)
1.688560E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.351400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.868800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.110000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.035900E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.219400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.882000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.876200E-02
Normal-vs-Daily Drinker
1.031640E-02
Normal-vs-Weekly Drinker
1.008180E-01
Normal-vs-Occasional Drinker
3.034200E-01
Normal-vs-Social Drinker
1.967210E-01
Non Drinker-vs-Daily Drinker
8.284400E-01
Non Drinker-vs-Weekly Drinker
4.346600E-01
Non Drinker-vs-Occasional Drinker
1.318840E-01
Non Drinker-vs-Social Drinker
4.092200E-01
Daily Drinker-vs-Weekly Drinker
2.365800E-01
Daily Drinker-vs-Occasional Drinker
8.404000E-02
Daily Drinker-vs-Social Drinker
3.123600E-01
Weekly Drinker-vs-Occasional Drinker
4.999400E-01
Weekly Drinker-vs-Social Drinker
9.294800E-01
Occasional Drinker-vs-Social Drinker
5.925200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.923400E-01
Normal-vs-Grade 2
5.964200E-02
Normal-vs-Grade 3
7.378000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.164300E-03
Grade 1-vs-Grade 3
1.056680E-03
Grade 1-vs-Grade 4
3.923400E-01
Grade 2-vs-Grade 3
1.755000E-01
Grade 2-vs-Grade 4
5.964200E-02
Grade 3-vs-Grade 4
7.378000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.571700E-02
Normal-vs-NonDiabetic
3.439700E-02
Diabetic-vs-NonDiabetic
7.160400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.546800E-01
Normal-vs-NoPancreatitis
3.330300E-02
Pancreatitis-vs-NoPancreatitis
1.805800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.498200E-02
Normal-vs-N1
4.281600E-02
N0-vs-N1
7.866800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.327900E-02
Normal-vs-TP53-NonMutant
8.058000E-03
TP53-Mutant-vs-TP53-NonMutant
6.750500E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
